Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,196 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07362914 | Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions(CHORD) | recruiting | Phase 3 | 182 | Fudan UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05954429 | A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study | recruiting | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Jan 22, 2026 |
| clinicaltrials |
| NCT07358520 | Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients | not yet recruiting | Phase 4 | 40 | Fudan UniversityOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT05909332 | Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) | recruiting | Phase 3 | 764 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06718010 | The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer | recruiting | — | 120 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07019363 | CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) | recruiting | Phase 3 | 1,903 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07355361 | Huaier Granule and Proteinuria(N093) | not yet recruiting | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07355855 | A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma | not yet recruiting | Phase 2 | 106 | Fudan UniversityOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05254847 | Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC | completed | Phase 2 | 65 | Fudan UniversityOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07353437 | Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco) | not yet recruiting | Phase 2 | 334 | Fudan UniversityOTHER | 0 | Jan 20, 2026 | clinicaltrials |
| NCT07347444 | Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma | not yet recruiting | Phase 2 | 48 | Fudan UniversityOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT05668884 | GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma | recruiting | Phase 2 | 93 | Fudan UniversityOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT06787313 | Precision Palliative Care for Patients With Advanced Esophageal Cancer | recruiting | — | 624 | Fudan UniversityOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT06849986 | IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)(TAIS) | recruiting | Phase 2 | 45 | Fudan UniversityOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06676449 | TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC | recruiting | Phase 3 | 432 | Fudan UniversityOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07324317 | Validation of End-to-End Difficult Airway Pathway Planning Algorithm (EAP-LC) | not yet recruiting | — | 70 | Eye & ENT Hospital of Fudan UniversityOTHER | 0 | Jan 7, 2026 | clinicaltrials |
| NCT05122377 | RWE About QOL and Compliance of Patients With OFS in China | completed | — | 562 | Fudan UniversityOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07318701 | Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy | not yet recruiting | N/A | 150 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 0 | Jan 6, 2026 | clinicaltrials |
| NCT07319949 | Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors | not yet recruiting | — | 30 | Fudan UniversityOTHER | 0 | Jan 6, 2026 | clinicaltrials |
| NCT06547736 | Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer | recruiting | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07316439 | Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer | active not recruiting | — | 197 | Fudan UniversityOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07312500 | Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer | active not recruiting | — | 3,000 | Fudan UniversityOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05494190 | The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma | recruiting | N/A | 111 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07308379 | Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer | not yet recruiting | — | 1,200 | Fudan UniversityOTHER | 0 | Dec 29, 2025 | clinicaltrials |
| NCT07304492 | AI for Renal Tumors Using Non-Contrast CT | not yet recruiting | — | 10,000 | Fudan UniversityOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07117890 | Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations(WU-KONG35) | recruiting | Phase 2 | 34 | Fudan UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT07303023 | Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC(INCIPT-NPC) | recruiting | Phase 3 | 462 | Fudan UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT07248956 | Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma | recruiting | Phase 2 | 116 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07296666 | Adjuvant Chemotherapy for BTC Based on 3D-PTA | not yet recruiting | Phase 2 | 98 | Fudan UniversityOTHER | 0 | Dec 22, 2025 | clinicaltrials |
| NCT07261683 | Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer | recruiting | Phase 2 | 20 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT07290153 | Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC(SCHBCC-N0105) | recruiting | — | 120 | Fudan UniversityOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07290166 | A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.(Cinderella-Neo) | not yet recruiting | Phase 2 | 42 | Fudan UniversityOTHER | 0 | Dec 18, 2025 | clinicaltrials |
| NCT07283575 | Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET) | recruiting | — | 497 | Fudan UniversityOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT05454358 | Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP | terminated | Phase 2 / Phase 3 | 12 | Fudan UniversityOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07272109 | Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes(PTCA199-16) | not yet recruiting | Phase 3 | 210 | Fudan UniversityOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07272382 | Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer(ESO-Shanghai28) | recruiting | N/A | 142 | Fudan UniversityOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07268794 | CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer(CONVERT-HB1) | not yet recruiting | Phase 2 | 112 | Fudan UniversityOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT04908696 | Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC) | recruiting | — | 1,000 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07262671 | Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer(MPE-NSCLC) | active not recruiting | — | 100 | Fudan UniversityOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07264556 | Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery | recruiting | N/A | 90 | Fudan UniversityOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05076682 | Reverse Triple Negative Immune Resistant Breast Cancer(Renaissance) | recruiting | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07261059 | AI-assisted Integrated Care to Promote Colonoscopy Uptake | not yet recruiting | N/A | 400 | Fudan UniversityOTHER | 0 | Dec 3, 2025 | clinicaltrials |
| NCT04193059 | Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer(PANSY) | active not recruiting | Phase 3 | 1,560 | Fudan UniversityOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06230055 | Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis | recruiting | Phase 4 | 37 | Fudan UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07249138 | Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study | completed | — | 800 | Children's Hospital of Fudan UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07243847 | Recurrence and Prognosis Prediction Model for Gastric Cancer | completed | — | 5,000 | Fudan UniversityOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT06449885 | A Cohort Study in Newly Diagnosed MZL | recruiting | — | 2,500 | Fudan UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07235566 | MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC | recruiting | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07236203 | Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study | recruiting | — | 80 | Fudan UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06143020 | Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction | completed | N/A | 100 | Fudan UniversityOTHER | 1 | Nov 17, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials